These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29608255)

  • 1. Twenty-five-year trajectories of insulin resistance and pancreatic β-cell response and diabetes risk in nonalcoholic fatty liver disease.
    VanWagner LB; Ning H; Allen NB; Siddique J; Carson AP; Bancks MP; Lewis CE; Carr JJ; Speliotes E; Terrault NA; Rinella ME; Vos MB; Lloyd-Jones DM
    Liver Int; 2018 Nov; 38(11):2069-2081. PubMed ID: 29608255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body mass index trajectories in young adulthood predict non-alcoholic fatty liver disease in middle age: The CARDIA cohort study.
    VanWagner LB; Khan SS; Ning H; Siddique J; Lewis CE; Carr JJ; Vos MB; Speliotes E; Terrault NA; Rinella ME; Lloyd-Jones DM; Allen NB
    Liver Int; 2018 Apr; 38(4):706-714. PubMed ID: 28963767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longer lactation duration is associated with decreased prevalence of non-alcoholic fatty liver disease in women.
    Ajmera VH; Terrault NA; VanWagner LB; Sarkar M; Lewis CE; Carr JJ; Gunderson EP
    J Hepatol; 2019 Jan; 70(1):126-132. PubMed ID: 30392752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty Liver, Insulin Resistance, and Obesity: Relationships With Increase in Coronary Artery Calcium Over Time.
    Sung KC; Ryu S; Lee JY; Lee SH; Cheong ES; Wild SH; Byrne CD
    Clin Cardiol; 2016 Jun; 39(6):321-8. PubMed ID: 26997000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese.
    Sung KC; Seo DC; Lee SJ; Lee MY; Wild SH; Byrne CD
    Nutr Metab Cardiovasc Dis; 2019 May; 29(5):489-495. PubMed ID: 30940491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Young Adult Physical Activity Trajectories and Midlife Nonalcoholic Fatty Liver Disease.
    de Brito JN; McDonough DJ; Mathew M; VanWagner LB; Schreiner PJ; Gabriel KP; Jacobs DR; Terry JG; Carr JJ; Pereira MA
    JAMA Netw Open; 2023 Oct; 6(10):e2338952. PubMed ID: 37862012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between glucose metabolism and non-alcoholic fatty liver disease severity in morbidly obese women.
    Bedogni G; Gastaldelli A; Tiribelli C; Agosti F; De Col A; Fessehatsion R; Sartorio A
    J Endocrinol Invest; 2014 Aug; 37(8):739-744. PubMed ID: 24906975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease.
    VanWagner LB; Ning H; Allen NB; Ajmera V; Lewis CE; Carr JJ; Lloyd-Jones DM; Terrault NA; Siddique J
    Gastroenterology; 2017 Nov; 153(5):1260-1272.e3. PubMed ID: 28802566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes?
    Gutierrez-Buey G; Núñez-Córdoba JM; Llavero-Valero M; Gargallo J; Salvador J; Escalada J
    Eur J Intern Med; 2017 Jun; 41():74-78. PubMed ID: 28283346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife.
    Sarkar M; Wellons M; Cedars MI; VanWagner L; Gunderson EP; Ajmera V; Torchen L; Siscovick D; Carr JJ; Terry JG; Rinella M; Lewis CE; Terrault N
    Am J Gastroenterol; 2017 May; 112(5):755-762. PubMed ID: 28291240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cadmium Exposure in Young Adulthood Is Associated with Risk of Nonalcoholic Fatty Liver Disease in Midlife.
    Li Y; Chen C; Lu L; Guo W; VanWagner LB; Shikany JM; Zhang S; Kahe K
    Dig Dis Sci; 2022 Feb; 67(2):689-696. PubMed ID: 33630217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
    Moh Moh MA; Jung CH; Lee B; Choi D; Kim BY; Kim CH; Kang SK; Mok JO
    Diab Vasc Dis Res; 2019 Mar; 16(2):186-195. PubMed ID: 30428692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline homeostasis model assessment of insulin resistance associated with fibrosis progression in patients with nonalcoholic fatty liver disease without diabetes: A cohort study.
    Koo DJ; Lee MY; Jung I; Moon SJ; Kwon H; Park SE; Rhee EJ; Lee WY
    PLoS One; 2021; 16(8):e0255535. PubMed ID: 34432804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
    Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
    J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease.
    Ajmera VH; Gunderson EP; VanWagner LB; Lewis CE; Carr JJ; Terrault NA
    Am J Gastroenterol; 2016 May; 111(5):658-64. PubMed ID: 27002796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Diabetes Mellitus and Insulin on Nonalcoholic Fatty Liver Disease in the Morbidly Obese.
    Strey CBM; de Carli LA; Fantinelli M; Gobbato SS; Bassols GF; Losekann A; Coral GP
    Ann Hepatol; 2018 July - August ,; 17(4):585-591. PubMed ID: 29893699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
    Cuthbertson DJ; Koskinen J; Brown E; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
    Ann Med; 2021 Dec; 53(1):1256-1264. PubMed ID: 34309471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of sex-specific body mass index and waist circumference trajectories with non-alcoholic fatty liver disease incidence based on growth mixture modeling.
    Cao T; Tong C; Li Q; Han Y; Halengbieke A; Ni X; Gao B; Zheng D; Yang X
    Nutr Metab Cardiovasc Dis; 2024 May; 34(5):1245-1256. PubMed ID: 38342721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.